Ras Al Khaimah Investment Authority v. Matrix Pharmacorp Private Limited & Anr. — 2026 INSC 932 (1 September 2026)
What the case was about
The dispute centres on efforts by a Ras Al Khaimah government investment authority to enforce a foreign money decree in India against businessman Nimmagadda Prasad. The authority, RAKIA, alleges that Prasad misappropriated funds entrusted to him for the VANPIC infrastructure project in Andhra Pradesh. After securing a judgment in the United Arab Emirates for approximately AED 267.9 million, RAKIA launched execution proceedings in Telangana under Section 44A of the Code of Civil Procedure, 1908. It then accused Prasad and a web of family-linked companies of rearranging corporate assets to frustrate recovery.
By the time the matter reached the Supreme Court, RAKIA was fighting on several fronts. It challenged interim orders of the Telangana High Court that had stayed contempt proceedings against Matrix Pharmacorp and Tianish Laboratories; the High Court’s ultimate dismissal of Contempt Case No. 1378 of 2024; the National Company Law Appellate Tribunal’s dismissal of appeals against the Matrix-Tianish merger; and the NCLAT’s parallel decision to allow cross-appeals that expunged protective conditions originally granted by the National Company Law Tribunal. All these appeals were heard together, presenting intertwined questions of comity between Indian and UAE courts, the limits of contempt law, and whether complex corporate restructuring could place assets beyond a creditor’s reach during execution.
The key facts
RAKIA, a public entity established under an Emiri Decree of the Ras Al Khaimah government, entrusted funds to Prasad for the VANPIC project. When the funds were allegedly misappropriated, RAKIA obtained the RAK Foreign Decree against Prasad and began execution proceedings in the Commercial Courts of Hyderabad and Ranga Reddy, treating the UAE judgment as enforceable in a reciprocating territory.
During the execution, IQuest Enterprises stated before the Commercial Court in Hyderabad that it would not acquire Viatris. RAKIA later argued that this statement was a binding undertaking, but the transaction was subsequently routed through Matrix Pharmacorp acquiring Tianish Laboratories. The NCLT sanctioned the Matrix-Tianish merger, but it imposed protective conditions in favour of the decree-holder. The NCLAT later expunged those safeguards. Meanwhile, the Telangana High Court dismissed RAKIA’s contempt proceedings, holding that IQuest’s affidavit was merely a clarificatory statement and not a contemptuous undertaking. RAKIA then approached the Supreme Court to safeguard the decree.
The questions before the Court
The Court had to decide four interlinked issues. First, did IQuest’s statement in its counter-affidavit before the Commercial Court amount to a clear, binding undertaking whose breach justified contempt? Second, had the respondents and Prasad acted in concert to dissipate or shield assets to frustrate execution of the foreign decree, and should the corporate veil be pierced? Third, did the NCLAT err in expunging the protective conditions the NCLT had imposed while sanctioning the merger? Fourth, should the Supreme Court maintain interim protection and direct the respondents to furnish additional security pending execution?
What the Court decided and why
A three-judge bench led by Chief Justice Surya Kant agreed with the Telangana High Court that IQuest’s statement was not contemptuous. Surveying the text of the counter-affidavit, the Court held that the words expressed only a present intention and lacked the “firm conviction” required of a solemn, express undertaking intended to be acted upon by the court. It was merely a clarificatory statement (para 59). Because no binding undertaking existed, no contempt could be made out against Matrix, Tianish or Moschip either.
Yet the Court refused to treat the surrounding corporate activity as harmless. It found that the series of transactions, together with the pervasive familial control exercised by Prasad and his immediate family over several corporate entities, gave rise to a genuine apprehension that assets could be dissipated to frustrate the decree (para 59). The Court emphasised that the RAK Foreign Decree was from a superior court of a reciprocating territory, and the principles of comity of nations demanded that it be given due weight even while passing interlocutory orders (para 62).
On the merger, the bench ruled that the NCLAT ought not to have disturbed the interim protections granted by the NCLT on 10 March 2025 in favour of the decree-holder (para 69).
Consequently, the Court modified the status quo orders. It directed Prasad and the respondent entities to jointly and severally furnish an additional security of ₹200 crores with the Supreme Court Registry within two weeks, over and above sums or assets already deposited. The encashment of this security will be subject to the outcome of the execution proceedings pending before the Commercial Courts (para 73).
Significantly, the Court stopped short of piercing the corporate veil in these proceedings. It left open the question whether Prasad’s family-controlled entities constitute a unified structure whose assets can be reached to satisfy the decree, directing that this issue be agitated before and decided by the executing Commercial Courts in Hyderabad and Ranga Reddy (para 74). It also directed those executing courts to decide the pending execution petitions and applications within four months.
Why it matters
The judgment draws a sharp line between casual clarifications made in court filings and binding undertakings that attract contempt, reinforcing that the contempt jurisdiction must be exercised with care and cannot be triggered by ambiguous statements (para 59). At the same time, it signals that courts will not permit judgment debtors to rotate assets through family-controlled firms during execution merely by invoking separate corporate personality. By mandating fresh security and restoring the NCLT’s interim protections, the Court has bolstered the position of foreign decree-holders under India’s reciprocal enforcement regime without prematurely collapsing corporate distinctions in summary proceedings. The four-month deadline for the executing courts also promises to reduce the prolonged uncertainty that often dogs cross-border judgment enforcement.